» Articles » PMID: 1703123

Liver Contains Heparin-binding Growth Factors As the Major Growth Factor for Cultured Fibroblasts

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1991 Jan 1
PMID 1703123
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of heparin-binding growth factors in liver was investigated by measuring the DNA synthesis stimulatory activity of liver extracts using quiescent fibroblasts as target cells. It was found that cytosolic fractions of mouse, rat and human liver, as well as isolated rat hepatocytes, contain a large amount of growth stimulatory activity. Most liver cytosolic activity is due to heparin-binding growth factors, because greater than 90% of the activity bound to a heparin affinity column in the presence of 0.8 mol/L NaCl, and was quantitatively eluted with 2 mol/L NaCl. Purification of these factors from both mouse and rat liver indicated the presence of both heparin-binding growth factor-1 and 2 in liver extracts. The level of the heparin-binding growth factors, as estimated from the biological activity, is approximately 1 microgram/gm mouse liver and 0.1 microgram/gm rat and human liver. Heparin-binding growth factor-1-like factors were 10 times as abundant as heparin-binding growth factor-2-like factors. These data indicate that the cytosolic fractions of mouse, rat and human liver contain heparin-binding growth factors as the primary growth factor for fibroblasts, and heparin binding growth factor-1-like molecules account for most of the cytosolic activity in both mouse and rat liver.

Citing Articles

The role of fibroblast growth factor signalling in Echinococcus multilocularis development and host-parasite interaction.

Forster S, Koziol U, Schafer T, Duvoisin R, Cailliau K, Vanderstraete M PLoS Negl Trop Dis. 2019; 13(3):e0006959.

PMID: 30849083 PMC: 6426264. DOI: 10.1371/journal.pntd.0006959.


Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

Prie D, Forand A, Francoz C, Elie C, Cohen I, Courbebaisse M PLoS One. 2013; 8(6):e66182.

PMID: 23825530 PMC: 3692511. DOI: 10.1371/journal.pone.0066182.


Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.

Yu C, Wang F, Jin C, Huang X, Miller D, Basilico C Am J Pathol. 2003; 163(4):1653-62.

PMID: 14507672 PMC: 1868310. DOI: 10.1016/S0002-9440(10)63522-5.


Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF).

Kan M, Yan G, Xu J, Nakahara M, Hou J In Vitro Cell Dev Biol. 1992; 28A(7-8):515-20.

PMID: 1381709 DOI: 10.1007/BF02634135.